Skip to main content

Table 3 Bivariate analysis of risk factors for Left ventricular Hypertrophy among hypertensive patients in Ethiopia

From: Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors

Predictor variables LVH ( N = 200 ) P-value
  Yes, N (%) No, N (%)  
Sex Female 78(68.4) 36(31.6) <0.001
Male 26(30.2) 60(69.8)
Age ≥50 years 92(61.7) 57(38.3) <0.001
<50 years 12(23.5 ) 39(76.5)
BMI ≥25 Kg/m2 40(57.1) 30(42.9) 0.172
<25 Kg/m2 64(49.2) 66(50.8)
SBP ≥140 mmHg 65(63.7) 37(36.3) <0.001
<140 mmHg 39(39.8) 59(60.2)
DBP ≥90 mmHg 56(56.0) 44(44.0) 0.258
<90 mmHg 48(48.0) 52(52.0)
History of DM Yes 20(51.3) 19(48.7) 0.920
No 84(52.2) 77(47.8)
Type of DM Type 2 15(53.6) 13(46.4) 0.897
Type 1 5(45.5) 6(54.5)
ACE inhibitor No 86(74.1) 30(25.9) <0.001
Yes 18(21.4) 66(78.6)
Beta Blocker Yes 43(57.3) 32(42.7) 0.242
No 61(48.8) 64(51.2)
Duration of hypertension ≥10 years 88(62.9) 52(37.1) <0.001
<10 years 16(26.7) 44(73.3)
Thiazide diuretic Yes 54(50.9) 52(49.1) 0.751
No 50(53.2) 44(46.8)
Calcium channel blocker Yes 9(47.4) 10(52.6) 0.671
  No 95(52.5) 86(47.5)  
  1. DM – diabetes mellitus, ACE – angiotensin converting enzyme.